ArticleFrontiers in public health2022

Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients.

Marcos Alejandro Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.